MolecularWeight: | 384.27 |
Formula: | C19H18BrN3O |
Purity: | ≥98% |
CAS#: | 856243-80-6 |
Solubility: | DMSOupto100mM |
ChemicalName: | (S,E)-3-(6-bromopyridin-2-yl)-2-cyano-N-(1-phenylbutyl)acrylamide |
Storage: | Powder:4oC1year.DMSO:4oC3month;-20oC1year. |
BIOLOGicalActivity:
WP1130(Degrasyn)isacell-permeable,potentandselectiveinhibitorofthedeubiquitinylatingenzymes(DUBs).At5μMitdirectlyinhibitsDUBactivityofUSP9x,USP5,USP14,UCH-L1,andUCH37,butnotUCH-L3,resultingindownregulationofantiapoptoticandupregulationofproapoptoticproteins,suchasMCL-1andp53.WP1130suppressesBcr/Abl,JAK2transducer(withoutaffecting20Sproteasome)andactivatoroftranscription(STAT).ItdidnotdirectlysuppressJak2kinaseactivity,butmediatedJak2ubiquitination,resultinginitstraffickingthroughHDAC6toperinuclearaggresomeswithoutcytokinestimulationorSOCS-1induction.
HowtoUse:
- Invitro:WP1130wasusedat5-10µMfinalconcentrationinvariousinvitroassays.
- Invivo:WP1130wasadmiNISTeredthroughIPinjectionat40mg/kgeveryotherday.
Reference:
- 1.BartholomeuszGA,etal.ActivationofanovelBcr/AbldestructionpathwaybyWP1130inducesapoptosisofchronicmyelogenousleukemiacells.(2007)Blood.109(8):3470-8.
- 2.BartholomeuszG,etal.Degrasynactivatesproteasomal-dependentdegradationofc-Myc.(2007)CancerRes.67(8):3912-8.
- 3.KapuriaV,etal.Deubiquitinaseinhibitionbysmall-moleculeWP1130triggersaggresomeformationandtumorcellapoptosis.(2010)CancerRes.70(22):9265-76.
- 4.SunH,etal.Bcr-AblubiquitinationandUsp9xinhibitionblockkinasesignalingandpromoteCMLcellapoptosis.(2011)Blood.117(11):3151-62.
- 5.KapuriaV,etal.AnovelsmallmoleculedeubiquitinaseinhibitorblocksJak2signalingthroughJak2ubiquitination.(2011)CellSignal.23(12):2076-85.
- WP1130_spec.pdf
- WP1130_MSDS.pdf
Productsareforresearchuseonly.Notforhumanuse